| abstract |
Described herein are novel compositions comprising at least one cannabinoid, sulfobutylether beta cyclodextrin, and vitamin E TPGS. These compositions are suitable for oral administration and have high concentrations of cannabinoids, while maintaining stability and favorable physical and biological characteristics. Also described herein are methods of treatment of diseases comprising administering to a patient in need thereof an oral composition comprising at least one cannabinoid, sulfobutylether beta cyclodextrin, and vitamin E TPGS. |